Evaluation of the efficacy, tolerability and cycle control of a monophasic oral contraceptive containing gestodene and ethinylestradiol (Minulet^®) in women over 35 years of age

R. P. Andrade Univcrsidade Federal do Paraná, Curitiba, Brazil

L. F. Aguiar Associação Maternidade São Paulo, São Paulo, Brazil

J. M. Aldrighi Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo, Brazil

I. C. Barbosa Universidade Federal da Bahia, Salvador, Brazil

R. P. Bossemeyer Instituto de Saude Reprodutiva de Santa Maria, Santa Maria, Brazil

R. Hegg Faculdade de Medicina da Universidade de São Paulo, São Paulo, Universidade Federal de Pernambuco, Recife, Brazil

J. W. B. Leal Pontificie Universidade Católica, Sorocaba, Brazil

L. S. Neto Santa Casa de Misericordia do Rio de Janeiro, Rio de Janeiro, Brazil

A. S. Pereira Maternidade Escola Vila Nova Cachoeirinha, São Paulo, Brazil

A. Vara Maternidade Escola Vila Nova Cachoeirinha, São Paulo, Brazil

show all

References

Mann J.I., Inman W. H. W. Oral contraceptives and death from myocardial infarction. Br. Med. J. 1975; 2: 245–8
PubMed Web of Science ®Google Scholar
Kuenssberg E.V., Dewhurst J. Mortality in women on oral contraceptives. Lancet 1977; 2: 757
PubMed Web of Science ®Google Scholar
Croft P., Hannaford P.C. Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraceptive study. Br. Med. J. 1989; 298: 165–8
PubMed Web of Science ®Google Scholar
Kirkman R. J.E., Pedersen J.H., Fioretti P., Roberts H.E. Clinical comparison of two low-dose oral contraceptives, 30 Jig EE/75 Jig ges-todene and 20 fig EE/150 Jig desogestrel, in women over 30 years of age. Contraception 1994; 49: 33–46
PubMed Web of Science ®Google Scholar
Latin American Oral Contraceptive Study Group. Clinical comparison ofmonophasic oral contraceptive preparations of gestodene/ethinylestradiol and desogestrel/ethinylestradiol. Contraception 1994; 50: 201–14
PubMed Web of Science ®Google Scholar
Brill K., Müller C., Schnitker J., Albring M. The influence of different modern low-dose oral contraceptives on intermenstrual bleeding. Adv. Contracept. 1991; 7(Suppl. 2)51–61
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Evaluation of the efficacy, tolerability and cycle control of a monophasic oral contraceptive containing gestodene and ethinylestradiol (Minulet^®) in women over 35 years of age

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Evaluation of the efficacy, tolerability and cycle control of a monophasic oral contraceptive containing gestodene and ethinylestradiol (Minulet®) in women over 35 years of age

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Evaluation of the efficacy, tolerability and cycle control of a monophasic oral contraceptive containing gestodene and ethinylestradiol (Minulet^®) in women over 35 years of age